-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Fortress Biotech, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2018 to Q3 2025.
- Fortress Biotech, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 33.1M shares, a 68% increase year-over-year.
- Fortress Biotech, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 20.8M shares, a 156% increase from 2023.
- Fortress Biotech, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 8.11M shares, a 36.9% increase from 2022.
- Fortress Biotech, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 5.92M shares, a 92.7% decline from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)